Skip to main contentAll experts

Laura Ranum

DIS PROF

MD-MOLECULAR GENTCS - MICROBIO

Orcid identifier0000-0001-9808-9661 (opens in a new tab)⁠
  • DIS PROF
    MD-MOLECULAR GENTCS - MICROBIO

GRANTS

  • GRANT
    Characterization of a DM2 BAC transgenic mouse model
    Myotonic Dystrophy Foundation18 Feb 2026 - 31 Dec 2027
    Active
  • GRANT
    Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD
    National Institute of Health Ninds28 Aug 2025 - 31 Aug 2027
    Active
  • GRANT
    Novel repeat associated non-AUG (RAN) proteins in sALS, sFTD and SBMA: shared pathological features and unifying therapeutic opportunities
    National Institute of Health Ninds7 Jul 2025 - 30 Jun 2027
    Active
  • GRANT
    Proof of concept testing of an anti-GA immunotherapy for C9orf72 ALS/FTD
    Latus Bio1 May 2025 - 30 Apr 2027
    Active
  • GRANT
    10th International Unstable Microsatellites and Human Disease Meeting
    National Institute of Health Ninds29 Nov 2024 - 30 Nov 2025
    Expired
  • GRANT
    Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center
    National Institute of Health Ninds5 Aug 2024 - 31 Jul 2028
    Active
  • GRANT
    Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias
    US Army Med Research Acquisition1 Apr 2024 - 31 Mar 2028
    Active
  • GRANT
    Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias
    Congressionally Directed Medical Research Programs1 Apr 2024 - 31 Mar 2028
    People funded by this grant:
    • RANUM LP
  • GRANT
    Anti-RAN targeting immunotherapy for C9orf72 ALS and genetically unknown RAN-positive sporadic ALS
    US Army Med Research Acquisition8 Sep 2023 - 30 Apr 2026
    Expired
  • GRANT
    Safety of Metformin in C9orf72 ALS: Effects on RAN Proteins, Breathing, Imaging, and Metabolomic Outcome Measures
    Congressionally Directed Medical Research Programs1 Sep 2023 - 31 Aug 2026
    People funded by this grant:
    • RANUM LP
  • GRANT
    Understanding and Targeting Common Mechanisms of Myotonic Dystrophy Types 1 and 2 Using Novel Repeat Expansion Mouse Models
    Congressionally Directed Medical Research Programs1 Sep 2023 - 31 Aug 2027
    People funded by this grant:
    • RANUM LP
  • GRANT
    Understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models
    US Army Med Research Acquisition22 Aug 2023 - 31 Aug 2027
    Active
  • GRANT
    Safety of Metformin in C9orf72 ALS: Effects on RAN Proteins, Breathing, Imaging, and Metabolomic Outcome Measures
    US Army Med Research Acquisition14 Aug 2023 - 31 Aug 2026
    Active
  • GRANT
    Anti-RAN Targeting Immunotherapy for C9orf72 ALS and Genetically Unknown RAN-Positive Sporadic ALS
    Congressionally Directed Medical Research Programs1 May 2023 - 30 Apr 2026
    People funded by this grant:
    • RANUM LP
  • GRANT
    Repeat associated non-AUG (RAN) proteins in FA: contribution to disease and therapeutic opportunities
    Friedreichs Ataxia Research Alliance21 Feb 2023 - 28 Feb 2025
    Expired
  • GRANT
    An RNA-based nanoparticle vaccine approach for the prevention and treatment of C9orf72 ALS/FTD
    US Army Med Research Acquisition15 Feb 2023 - 14 Feb 2026
    Expired
  • GRANT
    Safety & therapeutic potential of metformin for C9orf72 ALS
    Amyotrophic Lateral Sclerosis Association20 Dec 2022 - 30 Nov 2024
    Expired
  • GRANT
    Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD
    National Institute of Health Ninds19 Sep 2022 - 31 Aug 2025
    Expired
  • GRANT
    Identifying and targeting novel repeat associated non-AUG (RAN) proteins in sporadic ALS
    US Army Med Research Acquisition15 Jul 2022 - 14 Jul 2026
    Expired
  • GRANT
    Identifying and Targeting Novel Repeat-Associated Non-AUG (RAN) Proteins in Sporadic ALS
    Congressionally Directed Medical Research Programs15 Jul 2022 - 14 Jul 2026
    People funded by this grant:
    • RANUM LP
  • GRANT
    Novel repeat associated non-AUG (RAN) proteins in sALS, sFTD and SBMA: shared pathological features and unifying therapeutic opportunities
    National Institute of Health Ninds23 Jun 2022 - 30 Jun 2025
    Expired
  • GRANT
    Characterization of a Novel BAC Transgenic Mouse Model for DM2
    17 Mar 2022 - 31 Dec 2023
    Expired
  • GRANT
    Using mitochondrial Ca2+ uptake as a therapeutic target for ALS
    National Institute of Health Ninds19 Jul 2021 - 31 Jul 2023
    Expired
  • GRANT
    Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases
    National Institute of Health Ninds14 Jul 2021 - 30 Jun 2027
    Active
  • GRANT
    RAN proteins in sporadic ataxias and SCA8: diagnostic tools and therapeutic potential of metformin
    26 Feb 2021 - 28 Feb 2022
    Expired